CU23334A1 - Vacuna de vibrio cholerae inactivada en tabletas - Google Patents

Vacuna de vibrio cholerae inactivada en tabletas

Info

Publication number
CU23334A1
CU23334A1 CU20030061A CU20030061A CU23334A1 CU 23334 A1 CU23334 A1 CU 23334A1 CU 20030061 A CU20030061 A CU 20030061A CU 20030061 A CU20030061 A CU 20030061A CU 23334 A1 CU23334 A1 CU 23334A1
Authority
CU
Cuba
Prior art keywords
vibrio cholerae
vaccine
inactivated
tablets
vaccines
Prior art date
Application number
CU20030061A
Other languages
English (en)
Inventor
Suarez Caridad Torres
Quinoy Jose Luis Perez
Imia Luis Guillermo Garcia
Marrero Barbara Cedre
Perez Tania Balmaseda
Sanchez Hilda Maria Garcia
Navarro Yadira Pino
Fernandez Jorge Luis Castano
Lopez Gemma Ano
Hernandez Evangelina Urribarri
Coronel Arturo Talavera
Original Assignee
Inst Finlay
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Finlay filed Critical Inst Finlay
Priority to CU20030061A priority Critical patent/CU23334A1/es
Priority to PE2004000270A priority patent/PE20041064A1/es
Priority to ARP040100865A priority patent/AR043621A1/es
Priority to EP04721813A priority patent/EP1614427A1/en
Priority to JP2006504217A priority patent/JP2006520332A/ja
Priority to CA002519225A priority patent/CA2519225A1/en
Priority to BRPI0408409-8A priority patent/BRPI0408409A/pt
Priority to US10/549,992 priority patent/US20060246094A1/en
Priority to CNA2004800135037A priority patent/CN1791426A/zh
Priority to KR1020057016763A priority patent/KR20050109978A/ko
Priority to PCT/CU2004/000005 priority patent/WO2004082711A1/es
Priority to EC2005005997A priority patent/ECSP055997A/es
Priority to ZA200507576A priority patent/ZA200507576B/en
Publication of CU23334A1 publication Critical patent/CU23334A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/107—Vibrio
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K2039/106—Vibrio; Campylobacter; Not used, see subgroups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invencion se relaciona con el campo de las vacunas, específicamente con las vacunas de aplicacion oral contra el colera. El objetivo tÉcnico que persigue es obtener una formulacion en tabletas de vacunas de cÉlulas enteras inactivadas de Vibrio cholerae. La invencion describe la formulacion del producto vacunal.
CU20030061A 2003-03-20 2003-03-20 Vacuna de vibrio cholerae inactivada en tabletas CU23334A1 (es)

Priority Applications (13)

Application Number Priority Date Filing Date Title
CU20030061A CU23334A1 (es) 2003-03-20 2003-03-20 Vacuna de vibrio cholerae inactivada en tabletas
PE2004000270A PE20041064A1 (es) 2003-03-20 2004-03-12 Vacuna de vibrio cholerae inactivada en tabletas
ARP040100865A AR043621A1 (es) 2003-03-20 2004-03-16 Vacuna de vibrio cholerae inactivada en tabletas
EP04721813A EP1614427A1 (en) 2003-03-20 2004-03-19 Inactivated vibrio cholerae vaccine in tablet form
JP2006504217A JP2006520332A (ja) 2003-03-20 2004-03-19 錠剤状の不活化コレラ菌ワクチン
CA002519225A CA2519225A1 (en) 2003-03-20 2004-03-19 Inactivated vibrio cholerae vaccine in tablet form
BRPI0408409-8A BRPI0408409A (pt) 2003-03-20 2004-03-19 composição de vacina contra o cólera
US10/549,992 US20060246094A1 (en) 2003-03-20 2004-03-19 Inactivated vibrio cholerae vaccine in tablet form
CNA2004800135037A CN1791426A (zh) 2003-03-20 2004-03-19 片剂形式的灭活的霍乱弧菌疫苗
KR1020057016763A KR20050109978A (ko) 2003-03-20 2004-03-19 비활성화된 비브리오 콜레라 백신 타블렛
PCT/CU2004/000005 WO2004082711A1 (es) 2003-03-20 2004-03-19 Vacuna de vibrio cholerae inactivada en tabletas
EC2005005997A ECSP055997A (es) 2003-03-20 2005-09-02 Vacuna de vibrio cholerae inactivada en tabletas
ZA200507576A ZA200507576B (en) 2003-03-20 2005-09-19 Inactivated Vibrio cholerae vaccine in tablet form

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20030061A CU23334A1 (es) 2003-03-20 2003-03-20 Vacuna de vibrio cholerae inactivada en tabletas

Publications (1)

Publication Number Publication Date
CU23334A1 true CU23334A1 (es) 2008-12-24

Family

ID=40203015

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20030061A CU23334A1 (es) 2003-03-20 2003-03-20 Vacuna de vibrio cholerae inactivada en tabletas

Country Status (13)

Country Link
US (1) US20060246094A1 (es)
EP (1) EP1614427A1 (es)
JP (1) JP2006520332A (es)
KR (1) KR20050109978A (es)
CN (1) CN1791426A (es)
AR (1) AR043621A1 (es)
BR (1) BRPI0408409A (es)
CA (1) CA2519225A1 (es)
CU (1) CU23334A1 (es)
EC (1) ECSP055997A (es)
PE (1) PE20041064A1 (es)
WO (1) WO2004082711A1 (es)
ZA (1) ZA200507576B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2477649T3 (pl) * 2009-09-16 2017-06-30 Msd Wellcome Trust Hilleman Laboratories Pvt Ltd. Szczepionka przeciwko biegunce powodowanej przez cholerę i enterotoksynogenną e. coli (etec)
MY190074A (en) * 2018-01-09 2022-03-24 Aimst Univ A monovalent vaccine formulation and a method for preparation thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873090A (en) * 1985-03-27 1989-10-10 Broncostat Pty. Limited Non-adjuvenated vaccine
US4871546A (en) * 1987-06-29 1989-10-03 Sandoz Pharm. Corp. Gastrointestinal protective coating formulations
IT1260505B (it) * 1992-06-01 1996-04-09 Poli Ind Chimica Spa Sistemi farmaceutici orali a cessione ritardata per il rilascio specifico nel colon
US6203799B1 (en) * 1993-07-01 2001-03-20 Presidents And Fellows Of Harvard College Vibrio cholerae mutants which are soft-agar penetration defective and lack a functional CtxA subunit

Also Published As

Publication number Publication date
CN1791426A (zh) 2006-06-21
US20060246094A1 (en) 2006-11-02
EP1614427A1 (en) 2006-01-11
AR043621A1 (es) 2005-08-03
ZA200507576B (en) 2007-01-31
CA2519225A1 (en) 2004-09-30
WO2004082711A1 (es) 2004-09-30
BRPI0408409A (pt) 2006-03-21
PE20041064A1 (es) 2005-03-02
ECSP055997A (es) 2006-01-27
KR20050109978A (ko) 2005-11-22
JP2006520332A (ja) 2006-09-07

Similar Documents

Publication Publication Date Title
CL2019000209A1 (es) Formulación novedosa administrable por la vía oral.
CY1121107T1 (el) Φαρμακοτεχνικες μορφες δισκιων αμεσης απελευθερωσης
UY31350A1 (es) (carboxilalquilenfenil)feniloxamidas, procedimiento para su preparación y su utilización como medicamentos
CO6501190A2 (es) Vacuna de pcsk9
UY30472A1 (es) Nuevos derivados de pirimidina, procesos para su preparacion composiciones farmacéuticas conteniédolos, procesos para su preparacion y aplicaciones.
CO6491060A2 (es) Compuestos y composiciones para el tratamiento de enfermedades parasitarias
CR8569A (es) Inhibidores de integrasa de vih
MX2020008616A (es) Rocio de fentanilo sublingual.
EA201001577A1 (ru) Ингибитор дпп-4 в комбинации с дополнительным противодиабетическим агентом, таблетки, включающие указанные композиции, их применение и способ их получения
CO6480932A2 (es) Antagonistas de la trayectoria hedgehog de ftalazina disustituida.
UY29395A1 (es) Formulación de medicamentos conteniendo vardenafilo.
AR054188A1 (es) Aminas ciclicas con actividad inhibitoria del factor de coagulacion xa, metodos para su sintesis, intermediarios del proceso de obtencion de las mismas y su elaboracion, composiciones farmaceuticas que las contienen y su uso en la preparacion de medicamentos para el tratamiento de enfermedades del a
UA99645C2 (ru) Гель, имеющий противовоспалительное и противоаллергическое действие
NO20084478L (no) Konjugerte lipidderivater
TNSN07337A1 (en) Pharmaceutical composition comprising an indolylmaleimide derivative
CR20150266A (es) Formulaciones de liberación modificada para oprozomib
CO6420389A2 (es) Composiciones y métodos para el tratamiento y prevención de la enfermedad cardiovascular
AR103648A1 (es) Terapia de combinación contra el cáncer
CL2010000281A1 (es) Formulacion oral en forma de tableta de 9-[(2,2-dimetil-propilamino)-metil]-minociclina; metodo de preparacion; formulacion inyectable del mismo; utiles en el tratamiento de una infeccion.
UA96794C2 (ru) Глюкокортикоиды, способ их применения, способ лечения и фармацевтическая композиция на их основе
ATE526015T1 (de) Arzneimittel sowie deren herstellung und verwendung bei der behandlung von schmerzhaften neuropathien
GT200800235A (es) Formulacion de medicamento liquida
CU23334A1 (es) Vacuna de vibrio cholerae inactivada en tabletas
MX2009012713A (es) Nuevos derivados de acido 3-fenil acrilico de receptores de tipo ppar, su metodo de preparacion y su uso en composiciones cosmeticas o farmaceuticas.
PA8661701A1 (es) Tiazolidinonas, su preparacion y su uso como medicamento